STOCK GOODIES PLAYS OF THE WEEK

[SmallCapStockGuy]

LXGTF NEWS:

HeartSentry 1st generation product has successfully passed all requisite bench tests in preparation for upcoming clinical trials and the units have been formally released and delivered to Diablo Clinical Research.

Lexington’s President Eric Willis comments, “The team has worked diligently over the past several months to ensure the product is ready for human trials. As of today, we have signed off on all operational aspects of the device, including the documentation for operation and data interpretation. The product has been transferred to the investigative team and we have completed the device and study training with the researchers. We look forward to enrolling the first patients very soon and are excited to have our product in the hands of clinical professionals who we are certain will do a very thorough job of examining HeartSentry’s efficacy. I am pleased to report we are now one step closer to providing what is currently being discussed as a potentially disruptive tool in the early diagnosis of heart disease for healthcare professionals as well as patients around the world.”

https://finance.yahoo.com/news/lexington-delivers-1st-generation-heartsentry-140000547.html